Disappointing to close on the day's low.
Apart from the relationship with the US Advisors, a deal with Adheris hasn't been mentioned in previous announcement, so this comes as a surprise.
What has been published a number of times is PDX going live in April.
The next few months look busy. If they can turn these agreements into just 10% of the annual revenue numbers they're predicting, then H1FY20 looks to be where we see a step change in customer numbers and big pharma programs.
March - Adheris
April/May - PDX Inc
June/July - Zuellig
Ann: MedAdvisor Announces Agreement with Adheris Health SA, page-21
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $84.31K | 299.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 209547 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 94066 | 1 |
View Market Depth
| Last trade - 12.52pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
